Pharmalink

Pharmalink International Limited is a nutraceutical company formed in 1999 and registered in Hong Kong. The company was established to develop, market, and sell products derived from New Zealand green-lipped mussel oil. Its pet health brand, Antinol, is a natural anti-inflammatory joint supplement for dogs and cats containing a patented marine lipid extract called EAB-277, made from green-lipped mussel oil and krill oil. Antinol is produced using a proprietary CO2 supercritical extraction process at the company's facility in Nelson, New Zealand. The product is backed by over 60 clinical studies and sold in 47 countries. In Australia, Antinol is distributed through Vetz Petz Australia. Pharmalink International Limited is publicly held with shares traded over the counter in Hong Kong.